Diễn đàn tổng hợp công nghệ sức khỏe tài chính phụ nữ làm đẹp
Bạn có muốn phản ứng với tin nhắn này? Vui lòng đăng ký diễn đàn trong một vài cú nhấp chuột hoặc đăng nhập để tiếp tục.

Dr Reddy's: Covid vaccine-maker suffers cyber-attack

Go down

Dr Reddy's: Covid vaccine-maker suffers cyber-attack Empty Dr Reddy's: Covid vaccine-maker suffers cyber-attack

Bài gửi by nakanda Fri Oct 23, 2020 2:53 pm

Dr Reddy's: Covid vaccine-maker suffers cyber-attack _115032688_0310e319-afae-40e1-ba26-3a2e19fee87e

Pharmaceutical company Dr Reddy's, which is developing a Covid-19 vaccine, says it has been hit by a cyber-attack.

Sites around the world have been affected, including those in the UK, Brazil, India, Russia and the US.
The India-based company said it had isolated all of its data centre services to contain the attack.

Last week, Dr Reddy's was given permission to begin its final stage trials of Russia's Sputnik V Covid-19 vaccine.

Dr Reddy's: Covid vaccine-maker suffers cyber-attack _111445449_latest_index_promos_976index_vaccine_cv_976-nc

The company refused to comment on whether or not its manufacturing facilities had been affected.
The phone lines for the company's UK sites in Cambridgeshire and  slotxo Yorkshire appear to be down, but the company has not said if this is related.

Chief information officer Mukesh Rathi said: "In the wake of a detected cyber-attack, we have isolated all data centre services to take required preventive actions.

"We are anticipating all services to be up within 24 hours and we do not foresee any major impact on our operations due to this incident."

In India, local media have reported that production at some of Dr Reddy's facilities has been disrupted.

Dr Reddy's was established in 1986 and is headquartered in Hyderabad. It now develops and manufactures more than 200 products covering gastroenterology, oncology, pain management and cardiovascular conditions.

In the UK, Dr Reddy's is a supplier of medicines for the NHS, with a headquarters in Beverley, Yorkshire.

Last week it was announced that the company and Russia's sovereign wealth fund had received approval from the Drugs Controller General of India (DCGI) to conduct a human clinical trial of the Sputnik V Covid-19 vaccine in India.


Tổng số bài gửi : 37
Join date : 29/09/2020

Về Đầu Trang Go down

Về Đầu Trang

- Similar topics

Permissions in this forum:
Bạn không có quyền trả lời bài viết